Videos de Experimentos Relacionados
Moclobemida para el enrojecimiento de la menopausia.
Lancet (London, England)
|September 3, 1994
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes.
Metabolism: clinical and experimental·2021
Same author
The Heart Failure with Preserved Ejection Fraction Conundrum-Redefining the Problem and Finding Common Ground?
Current heart failure reports·2020
Same author
Attitudes of general hospital consultants towards psychosocial and psychiatric problems in Netherlands.
Psychology, health & medicine·2018
Same author
Longitudinal monitoring of anti-saliva antibodies as markers of repellent efficacy against Phlebotomus perniciosus and Phlebotomus papatasi in dogs.
Medical and veterinary entomology·2018
Same author
Development of a novel multiplexed qPCR and Pyrosequencing method for the detection of human pathogenic yersiniae.
International journal of food microbiology·2017
Same author
Northern Territory perspectives on heart failure with comorbidities – understanding trial validity and exploring collaborative opportunities to broaden the evidence base.
Heart, lung & circulation·2015
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026